Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Xolisa Mnukwa | Photo Tshepang Mahlatsi
Next Chapter
UFS Next Chapter prioritises mental health of students.

The conversation themed Who helps the helpers? kicked off with Next Chapter founder and spokesperson, Tshepang Mahlatsi, explaining the diversity and defining factors of the world, which are divided into a number of outlining categories, namely religion, social class, ethnic race, gender, age, and many other crucial aspects.

Tshepang explained that mental health outstrips all man-made boundaries because of one thing that the human race has in common, namely each individual’s capabilities to deal with stress. 

This conversation zoomed in on mental health within the Faculty of Health Sciences and its career spectrum.  According to Tshepang, “It is only in emergencies and extreme situations that people recall the importance of mental health, due to the stigma that surrounds the topic”.

Representatives from the Faculty of Health Sciences and the Department of Student Development and Counselling assembled in Metro 7 of the James Moroka Building to discuss ways of addressing the question Who helps the helpers?

Next Chapter, in collaboration with the Faculty of Health Sciences, further launched a power hour where certified health professionals are given a platform to address and interact with Health Sciences students in a safe and free environment.

Tshepang explained that the initiative strives to start a culture and create a space where anyone dealing with a mental illnesses or issue does not feel ashamed to seek help.

 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept